Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...

We review and compare the best options from Hims, Bluechew, and Ro. Erectile dysfunction (ED) meds like Viagra have a long and storied history. Sildenafil (Viagra), in particular, was first ...

Fortunately. Telehealth platforms like Hims, ZipHealth, Roman, and BlueChew cut the time and hassle out of accessing erectile dysfunction treatments so you can get back to having the sex life you ...

Most cases are due to physical causes, but there are also psychological factors that can contribute to or independently cause … ED pills, such as BlueChew and Hims, work by increasing blood flow to ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase, and achieved $126 million in GAAP net income. The company’s subscriber base reached 2.2 million ...

Hims & Hers is shutting down the dermatology business it acquired four years ago, Business Insider has learned. On Friday, the telehealth company discontinued Apostrophe, the direct-to-consumer ...

Hims & Hers Health is now reasonably valued after its large drop, making it a cautious Buy due to its high-growth potential. The company's revenue grew 69% YoY to $1.5 billion, driven by a 45% ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operations ...

Hims & Hers Health Inc (NYSE:HIMS) stock has had a roller coaster week. The shares gapped higher by 17.5% on Tuesday despite a downgrade, unironically, to "equal-weight" from "overweight" at ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

Financial giants have made a conspicuous bullish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health HIMS revealed 21 unusual trades. Delving into the details ...

Hims & Hers Health (NYSE: HIMS) stock took a tumble Thursday morning, falling 9.2% through 11:40 a.m. ET on some (vicariously) bad news out of the Great State of Texas. The U.S. District Court for ...